Text Size

A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice Guidelines for Children With Croup

This study has been terminated.
Sponsor:
Information provided by:
University of Calgary
ClinicalTrials.gov Identifier:
NCT00147849
First received: September 2, 2005
Last updated: November 28, 2005
Last verified: September 2005
History of Changes
  Purpose

The purpose of this study is to identify, from a societal perspective, the costs and associated benefits of three strategies for disseminating and implementing a practice guideline that addresses the management of croup.


Condition Intervention
Croup
 Behavioral: mailing of printed educational materials
Behavioral: a combination of interactive educational meetings, educational outreach visits, and reminders
Behavioral: identification of local opinion leaders and establishment of local consensus processes

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice

Further study details as provided by University of Calgary:

Primary Outcome Measures:
  • Rate of hospital days per 1,000 disease episodes

Secondary Outcome Measures:
  • Proportion of patients treated in the ED and hospital with a corticosteroid.
  • Proportion of patients evaluated in ED for at least three hours after treatment with corticosteroids before the decision to admit to hospital is made.
  • Time to treatment with corticosteroids in both ED and hospital patients.
  • An economic analysis conducted from a societal perspective with costs classified as either payer (costs born by the province) or non-payer (costs born by individuals or the families of children with croup).

Study Start Date: September 2000
Estimated Study Completion Date: March 2006
  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Alberta hospitals were rank ordered based on the number of disease episodes and rates of hospitalization for a six-year period. We then approached in this order each of the hospital administrators and clinical staff for permission to include their hospital in our study until a total of 24 hospitals consented

Exclusion Criteria:

  • Refusal by hospital staff to participate in this trial
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00147849

Sponsors and Collaborators
Canadian Institutes of Health Research (CIHR)
Investigators
Principal Investigator: David W Johnson, MD University of Calgary
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00147849     History of Changes
Other Study ID Numbers: MCT-63141, CIHR App No. 110642, U Calgary Acct. No. 73-1051
Study First Received: September 2, 2005
Last Updated: November 28, 2005
Health Authority: Canada: Health Canada

Keywords provided by University of Calgary:
knowledge translation
health care utilization
economic analysis

Additional relevant MeSH terms:
Croup
Laryngitis
Laryngeal Diseases
Respiratory Tract Diseases
Otorhinolaryngologic Diseases

ClinicalTrials.gov processed this record on May 21, 2013